• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Prognostic value of pan immune-inflammation value in patients undergoing unprotected left main coronary artery stenting.全免疫炎症值在无保护左主干冠状动脉支架置入患者中的预后价值
Biomark Med. 2024;18(21-22):957-967. doi: 10.1080/17520363.2024.2412515. Epub 2024 Oct 21.
2
The progression of non-culprit coronary lesion is related to higher SII, SIRI, and PIV in patients with ACS.在急性冠状动脉综合征（ACS）患者中，非罪犯冠状动脉病变的进展与较高的全身炎症反应指数（SII）、全身免疫炎症指数（SIRI）和血小板炎症反应指数（PIV）相关。
Medicine (Baltimore). 2024 Dec 27;103(52):e41094. doi: 10.1097/MD.0000000000041094.
3
Impact of Target Lesion Revascularization on Long-Term Mortality After Percutaneous Coronary Intervention for Left Main Disease.左主干病变经皮冠状动脉介入治疗后靶病变血运重建对长期死亡率的影响。
JACC Cardiovasc Interv. 2024 Jan 8;17(1):32-42. doi: 10.1016/j.jcin.2023.10.068.
4
Superiority of pan-immune inflammation value, systemic inflammation index, and CALLY scores prognostic value for mortality of ischemic stroke patients followed in intensive care unit.泛免疫炎症值、全身炎症指数和CALLY评分对重症监护病房中缺血性中风患者死亡率的预后价值优越性。
BMC Immunol. 2025 Jul 7;26(1):49. doi: 10.1186/s12865-025-00730-7.
5
Immune and Inflammation Markers as a Predictor of Overall Survival in Patients with Hematologic Malignancies: A Retrospective Cohort Study.免疫和炎症标志物作为血液系统恶性肿瘤患者总生存期的预测指标：一项回顾性队列研究
Medicina (Kaunas). 2025 May 30;61(6):1019. doi: 10.3390/medicina61061019.
6
Predicting the prognosis of diabetic patients undergoing percutaneous coronary intervention: the value of the Naples prognostic score in a real-world clinical study.预测接受经皮冠状动脉介入治疗的糖尿病患者的预后：那不勒斯预后评分在真实世界临床研究中的价值。
BMC Cardiovasc Disord. 2025 Jun 2;25(1):425. doi: 10.1186/s12872-025-04849-8.
7
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.冠状动脉旁路移植术与经皮冠状动脉介入治疗支架置入治疗冠状动脉疾病的死亡率：一项个体患者数据的合并分析。
Lancet. 2018 Mar 10;391(10124):939-948. doi: 10.1016/S0140-6736(18)30423-9. Epub 2018 Feb 23.
8
Comparison of long-term outcomes of minimally invasive coronary artery bypass grafting and percutaneous coronary intervention for left main disease.微创冠状动脉旁路移植术与经皮冠状动脉介入治疗左主干病变的长期疗效比较。
Coron Artery Dis. 2025 Aug 1;36(5):406-415. doi: 10.1097/MCA.0000000000001504. Epub 2025 Jan 17.
9
Stepwise Provisional Versus Systematic Dual-Stent Strategies for Treatment of True Left Main Coronary Bifurcation Lesions.治疗真性左主干冠状动脉分叉病变的逐步临时与系统性双支架策略
Circulation. 2025 Mar 4;151(9):612-622. doi: 10.1161/CIRCULATIONAHA.124.071153. Epub 2025 Feb 5.
10
The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.生物标志物对改良心脏风险指数在预测非心脏手术患者主要不良心脏事件和全因死亡率方面的比较和附加预后价值。
Cochrane Database Syst Rev. 2021 Dec 21;12(12):CD013139. doi: 10.1002/14651858.CD013139.pub2.

本文引用的文献

1
The relationship of pan-immune-inflammation value (PIV) and HALP score with prognosis in patients with atrial fibrillation.房颤患者中全免疫炎症值（PIV）和 HALP 评分与预后的关系。
Medicine (Baltimore). 2024 Sep 6;103(36):e39643. doi: 10.1097/MD.0000000000039643.
2
Association between the pan-immune-inflammation value and coronary collateral circulation in chronic total coronary occlusive patients.慢性全闭塞冠状动脉病变患者的全免疫炎症值与冠状动脉侧支循环的关系。
BMC Cardiovasc Disord. 2024 Aug 28;24(1):458. doi: 10.1186/s12872-024-04139-9.
3
Association of Pan Immune-Inflammation Value with Long Term Outcomes of Acute Decompensated Heart Failure.免疫炎症整体评分与急性失代偿性心力衰竭患者长期预后的相关性研究。
Arq Bras Cardiol. 2024 Jun;121(6):e20230817. doi: 10.36660/abc.20230817.
4
Could Pan-Immune-Inflammation Value be a Marker for the Diagnosis of Coronary Slow Flow Phenomenon?全免疫炎症值能否成为冠状动脉慢血流现象诊断的标志物？
Cardiovasc Toxicol. 2024 May;24(5):519-526. doi: 10.1007/s12012-024-09855-4. Epub 2024 Apr 15.
5
The Role of Pan-Immune-Inflammation Value in Determining the Severity of Coronary Artery Disease in NSTEMI Patients.全免疫炎症值在确定非ST段抬高型心肌梗死患者冠状动脉疾病严重程度中的作用
J Clin Med. 2024 Feb 25;13(5):1295. doi: 10.3390/jcm13051295.
6
The Role of Pan-Immune-Inflammation Value in Predicting Contrast-Induced Nephropathy Development in Patients Undergoing Percutaneous Coronary Intervention Due to NSTEMI.全免疫炎症值在预测因非ST段抬高型心肌梗死接受经皮冠状动脉介入治疗患者造影剂诱导的肾病发生中的作用
Angiology. 2025 Mar;76(3):281-288. doi: 10.1177/00033197231211107. Epub 2023 Oct 30.
7
High CRP-albumin ratio is associated high thrombus burden in patients with newly diagnosed STEMI.高 C 反应蛋白-白蛋白比值与新发 ST 段抬高型心肌梗死患者的高血栓负荷相关。
Medicine (Baltimore). 2023 Oct 13;102(41):e35363. doi: 10.1097/MD.0000000000035363.
8
Relationship between blood viscosity and thrombus burden in ST-segment elevation myocardial infarction.ST 段抬高型心肌梗死患者血液黏度与血栓负荷的关系。
Clin Hemorheol Microcirc. 2023;85(1):31-40. doi: 10.3233/CH-231756.
9
Associations between systemic immune-inflammation index and abdominal aortic calcification: Results of a nationwide survey.全身免疫炎症指数与腹主动脉钙化的相关性：一项全国性调查的结果。
Nutr Metab Cardiovasc Dis. 2023 Jul;33(7):1437-1443. doi: 10.1016/j.numecd.2023.04.015. Epub 2023 Apr 22.
10
Is the predictive value of systemic immune-inflammation index superior to traditional markers in ST-elevation myocardial infarction patients?全身免疫炎症指数在ST段抬高型心肌梗死患者中的预测价值是否优于传统标志物？
Coron Artery Dis. 2023 Jun 1;34(4):281. doi: 10.1097/MCA.0000000000001238. Epub 2023 Apr 25.

全免疫炎症值在无保护左主干冠状动脉支架置入患者中的预后价值

Prognostic value of pan immune-inflammation value in patients undergoing unprotected left main coronary artery stenting.

作者信息

Karaduman Ahmet, Yılmaz Cemalettin, Keten Mustafa Ferhat, Balaban İsmail, Kültürsay Barkın, Danışman Neşri, Tiryaki Muhammet Mucahit, Alizade Elnur, Zehir Regayip

机构信息

Department of Cardiology, Kartal Kosuyolu Research & Education Hospital, Denizer Road, Cevizli Crossroads, No: 2, 34840, Kartal, Istanbul, Turkey.

Department of Cardiology, Mus State Hospital, Saltukgazi Neighborhood, Hospital Street, 49400, Malazgirt, Mus, Turkey.

出版信息

Biomark Med. 2024;18(21-22):957-967. doi: 10.1080/17520363.2024.2412515. Epub 2024 Oct 21.

DOI:10.1080/17520363.2024.2412515
PMID:39431313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11633389/
Abstract

This study aimed long-term prognostic factors for percutaneous coronary intervention (PCI) in left main coronary artery (LMCA) disease, focusing on inflammatory parameters like Pan Immune-Inflammation Value (PIV) and Systemic Immune-Inflammation Index (SII). This retrospective, observational study involved 121 patients receiving unprotected LMCA PCI.The study's primary end point was MACE, including all-cause death, repeat revascularization and myocardial reinfarction. The PIV and SII scores emerged as independent predictors of MACE occurrence in patients undergoing PCI for unprotected LMCA disease (p:0.045,p:0.048;respectively).In addition, age, ejection fraction, creatinine, shock presentation and the residual syntax score were identified as significant independent predictors of MACE in both models. This study showed a significant, independent correlation between PIV, SII and MACE in patients undergoing PCI for LMCA disease, with PIV showing slightly better predictive capability than SII.

摘要

本研究旨在探讨左主干冠状动脉（LMCA）疾病经皮冠状动脉介入治疗（PCI）的长期预后因素，重点关注炎症参数，如全免疫炎症值（PIV）和全身免疫炎症指数（SII）。这项回顾性观察性研究纳入了121例接受非保护左主干冠状动脉PCI的患者。该研究的主要终点是主要不良心血管事件（MACE），包括全因死亡、再次血运重建和心肌再梗死。PIV和SII评分是接受非保护左主干冠状动脉疾病PCI患者发生MACE的独立预测因素（p值分别为0.045和0.048）。此外，在两个模型中，年龄、射血分数、肌酐、休克表现和残余SYNTAX评分均被确定为MACE的显著独立预测因素。本研究表明，在接受左主干冠状动脉疾病PCI的患者中，PIV、SII与MACE之间存在显著的独立相关性，PIV的预测能力略优于SII。